Celon Laboratories Private Limited — Actinomycin Exporter Profile
Indian Pharmaceutical Exporter · #4 for Actinomycin · $67.3K export value · DGFT Verified
Celon Laboratories Private Limited is the #4 Indian exporter of Actinomycin with $67.3K in export value and 16 verified shipments. Celon Laboratories Private Limited holds a 2.3% market share in Actinomycin exports across 10 countries. The company exports 13 pharmaceutical products worth $2.3M across 3 therapeutic categories.
Celon Laboratories Private Limited — Actinomycin Export Profile: Buyers & Destinations
Where Does Celon Laboratories Private Limited Export Actinomycin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| TAIWAN | $12.4K | 2 | 18.4% |
| COSTA RICA | $10.2K | 2 | 15.2% |
| PERU | $8.6K | 2 | 12.8% |
| TRINIDAD & TOBAGO | $7.8K | 1 | 11.5% |
| EL SALVADOR | $7.6K | 2 | 11.3% |
| DOMINICAN REPULIC | $5.5K | 3 | 8.2% |
| CHILE | $4.9K | 1 | 7.2% |
| HONDURAS | $4.5K | 1 | 6.7% |
| GAUTEMALA | $4.0K | 1 | 5.9% |
| ZIMBABWE | $1.8K | 1 | 2.7% |
Celon Laboratories Private Limited exports Actinomycin to 10 countries. The largest destination is TAIWAN accounting for 18.4% of Celon Laboratories Private Limited's Actinomycin shipments, followed by COSTA RICA (15.2%) and PERU (12.8%). These destinations reflect Celon Laboratories Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Actinomycin from Celon Laboratories Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| SEVEN PHARMA LTDA | COSTA RICA | $7.8K | 1 |
| VERNON TECHNOLOGIES LIMITED | TRINIDAD & TOBAGO | $7.8K | 1 |
| DRAGON PHARMACEUTICALS CO. LTD., | TAIWAN | $6.2K | 1 |
| DRAGON PHARMACEUTICALS CO.LTD | TAIWAN | $6.2K | 1 |
| SEVEN PHARMA EL SALVADOR S.A.DE C.V | EL SALVADOR | $5.8K | 1 |
| SEVEN PHARMA DR SRL | DOMINICAN REPULIC | $5.5K | 3 |
| SEVEN PHARMA S.A.C. | PERU | $5.4K | 1 |
| SEVEN PHARMA CHILE SPA | CHILE | $4.9K | 1 |
| SEVEN PHARMA HONDURAS S.A, | HONDURAS | $4.5K | 1 |
| SEVEN PHARMA GUATEMALA SA | GAUTEMALA | $4.0K | 1 |
Celon Laboratories Private Limited supplies Actinomycin to 14 buyers globally. The largest buyer is SEVEN PHARMA LTDA (COSTA RICA), followed by VERNON TECHNOLOGIES LIMITED (TRINIDAD & TOBAGO) and DRAGON PHARMACEUTICALS CO. LTD., (TAIWAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Actinomycin Export Value and How Much Does Celon Laboratories Private Limited Contribute?
India exported $882.7K worth of Actinomycin through 933 shipments from 184 suppliers to 97 countries, serving 351 buyers globally. Celon Laboratories Private Limited contributes $67.3K to this total, accounting for 2.3% of India's Actinomycin exports. Celon Laboratories Private Limited ships Actinomycin to 10 countries through 14 buyers.
What Is the Average Shipment Value for Celon Laboratories Private Limited's Actinomycin Exports?
Celon Laboratories Private Limited's average Actinomycin shipment value is $4.2K per consignment, based on 16 shipments totaling $67.3K. The largest destination is TAIWAN (18.4% of Celon Laboratories Private Limited's Actinomycin exports).
How Does Celon Laboratories Private Limited Compare to Other Indian Actinomycin Exporters?
Celon Laboratories Private Limited ranks #4 among 184 Indian Actinomycin exporters with a 2.3% market share. The top 3 exporters are EUGIA PHARMA SPECIALITIES LIMITED ($250.0K), MYLAN LABORATORIES LIMITED ($200.0K), IKRIS PHARMA NETWORK PRIVATE LIMITED ($108.1K). Celon Laboratories Private Limited processed 16 shipments to 10 destination countries.
What Actinomycin Formulations Does Celon Laboratories Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| DACTIVEN 0.5 DACTINOMYCIN INJ 0.5MG | $10.3K | 2 |
| DACTINOMYCIN INJ USP 0.5MG | $7.8K | 1 |
| DACTINOMYCIN INJ 0.5MG1000NOS | $7.8K | 1 |
| DACTILON 0.5 DACTINOMYCIN INJECTION USP0.5MG500NOS | $6.2K | 1 |
| DACTILON 0.5 (DACTINOMYCIN INJ. 0.5MG) ( | $6.2K | 1 |
| DACTILON 0.5 (DACTINOMYCIN INJECTION USP0.5MG) | $5.4K | 1 |
| DACILON 0.5(DACTINOMYCIN INJ.USP 0.5MG) | $4.9K | 1 |
| DACTIVEN 0.5 DACTINOMYCIN ING.0.5MG500NOS | $4.0K | 1 |
| DACTILON 0.5 (DACTINOMYCIN INJ.0.5MG) | $3.3K | 1 |
| TINODAC 0.5(DACTINOMYCIN INJ.0.5MG) | $3.1K | 2 |
Celon Laboratories Private Limited exports 14 distinct Actinomycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DACTIVEN 0.5 DACTINOMYCIN INJ 0.5MG with 2 shipments worth $10.3K.
How Does Celon Laboratories Private Limited Compare to Nearest Actinomycin Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | MYLAN LABORATORIES LIMITED | $200.0K | 4 | 1 | $50.0K |
| 3 | IKRIS PHARMA NETWORK PRIVATE LIMITED | $108.1K | 103 | 1 | $1.0K |
| 4 | CELON LABORATORIES PRIVATE LIMITED ★ | $67.3K | 16 | 10 | $4.2K |
| 5 | GNH INDIA PHARMACEUTICALS LIMITED | $53.4K | 56 | 4 | $953 |
| 6 | VAMA LIFECARE PRIVATE LIMITED | $44.7K | 59 | 5 | $757 |
Celon Laboratories Private Limited ranks #4 among 184 Indian Actinomycin exporters. Average shipment value of $4.2K compared to the market average of $4.8K. The closest competitors by value are MYLAN LABORATORIES LIMITED and IKRIS PHARMA NETWORK PRIVATE LIMITED.
Which Indian Ports Ship Actinomycin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 304 | 32.6% |
| SAHAR AIR CARGO ACC (INBOM4) | 184 | 19.7% |
| DELHI AIR | 108 | 11.6% |
| Bombay Air | 82 | 8.8% |
| DELHI AIR CARGO ACC (INDEL4) | 62 | 6.6% |
| AHEMDABAD AIR | 21 | 2.3% |
| Bombay Air Cargo | 20 | 2.1% |
| Delhi Air | 18 | 1.9% |
What Other Advanced Oncology Products Does Celon Laboratories Private Limited Export?
Celon Laboratories Private Limited also exports these advanced oncology products. Each links to the detailed product page.
About Celon Laboratories Private Limited
Celon Laboratories Private Limited exports 13 products worth $2.3M. Beyond Actinomycin, top products include Carboplatin, Oxaliplatin, Cytarabine, Bleomycin, Exemestane. View the complete Celon Laboratories Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Actinomycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Actinomycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Celon Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 16 individual customs records matching Celon Laboratories Private Limited exporting Actinomycin, covering 14 formulations to 10 countries via 14 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 97+ countries, 351+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Actinomycin Export Data from Celon Laboratories Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Celon Laboratories Private Limited's Actinomycin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Celon Laboratories Private Limited
Full Company Profile →
13 products · $2.3M total trade · 3 categories
Actinomycin Stats
Company Overview
Top Products by Celon Laboratories Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Celon Laboratories Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Actinomycin. For current shipment-level data, contact TransData Nexus.